The FDA Just Authorized the First COVID-19 Pill, a Pfizer Drug That Can Be Taken At Home
U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus.
The long-awaited milestone comes as U.S. cases, hospitalizations and deaths are all rising and health officials warn of a tsunami of new infections from the omicron variant that could overwhelm hospitals.
The drug, Paxlovid, is a faster, cheaper way to treat early COVID-19 infections, though initial supplies will be extremely limited. All of the previously authorized drugs against the disease require an IV or an injection.
[time-brightcove not-...
Source: TIME: Health - December 22, 2021 Category: Consumer Health News Authors: MATTHEW PERRONE / AP Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news
PreHevbrio (Hepatitis B Vaccine (Recombinant) Injectable Suspension) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 20, 2021 Category: Drugs & Pharmacology Source Type: news
New Hepatitis B Vaccination Recommendations Praised New Hepatitis B Vaccination Recommendations Praised
With hepatitis B vaccination rates low and infection rates rising, experts hope the new recommendations will raise clinician awareness and simplify screening.Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - December 17, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news
FDA Approves PreHevbrio (Hepatitis B Vaccine (Recombinant)) for the Prevention of Hepatitis B in Adults
PreHevbrio™ is the only approved 3-antigen hepatitis B vaccine for adults in the U.S.
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease,... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 1, 2021 Category: Drugs & Pharmacology Source Type: news
FDA Panel Narrowly Backs a First-of-a-Kind COVID-19 Antiviral Pill Made By Merck
WASHINGTON (AP) — A panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the coronavirus.
A Food and Drug Administration (FDA) panel voted 13-10 that the drug’s benefits outweigh its risks, including potential birth defects if used during pregnancy. The recommendation came after hours of debate about the drug’s modest benefits and potential safety issues. Experts backing the treatment stressed that it should not be used by anyone who is pregnant and call...
Source: TIME: Health - November 30, 2021 Category: Consumer Health News Authors: MATTHEW PERRONE / AP Tags: Uncategorized COVID-19 wire Source Type: news
Customers who visited a New Jersey Starbucks are told to get vaccinated against hepatitis A
An employee who worked at a Starbucks location in New Jersey, has tested positive for hepatitis A and may have been exposed between November 4 and November 6 or between November 11 and 13. (Source: the Mail online | Health)
Source: the Mail online | Health - November 19, 2021 Category: Consumer Health News Source Type: news
Pfizer Says COVID-19 Pill Cuts Hospital And Death Risk By 90%
(WASHINGTON) — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joins the race to bring the first easy-to-use medication against the coronavirus to the U.S. market.
Currently all COVID-19 treatments used in the U.S. require an IV or injection. Competitor Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and on Thursday the United Kingdom became the first country to OK it.
Pfizer said it will ask the FDA and international regulat...
Source: TIME: Health - November 5, 2021 Category: Consumer Health News Authors: Matthew Perrone/ AP Tags: Uncategorized COVID-19 wire Source Type: news
ACIP Recommends Universal HBV Vaccination for Adults Under 60 ACIP Recommends Universal HBV Vaccination for Adults Under 60
Will the universal recommendation help reinvigorate stalling declines in hepatitis B infections over the past decade?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 4, 2021 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Panel: All US adults under 60 should get hepatitis B shots
A federal advisory committee has recommended that all U.S. adults younger than 60 be vaccinated against hepatitis B (Source: ABC News: Health)
Source: ABC News: Health - November 3, 2021 Category: Consumer Health News Tags: Health Source Type: news
The Big Number: At least 27 vaccines are available in the U.S.
They include ones to prevent polio, diphtheria, hepatitis, tetanus, whooping cough, mumps, measles, the flu and other diseases. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - October 30, 2021 Category: Consumer Health News Authors: Linda Searing Source Type: news
New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately to severely acti...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
CDC: Advisory Committee on Immunization Practices (ACIP)
Notice that the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) is hosting a virtual meeting on November 2-3, 2021. The agenda will include discussions on adult immunization schedule, child/adolescent immunization schedule, Ebola vaccine, hepatitis vaccines, Orthopoxviruses vaccine, and COVID vaccines. Includes information on how to submit public comments or request permission to make a public comment during the meeting. Registration is not required, and the meeting is open to the public, available online via a live webcast. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - October 22, 2021 Category: Rural Health Source Type: news
Public Inspection: CDC: Meetings: Advisory Committee on Immunization Practices
Pre-publication notice that the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) is hosting a virtual meeting on November 2-3, 2021. The agenda will include discussions on adult immunization schedule, child/adolescent immunization schedule, Ebola vaccine, hepatitis vaccines, Orthopoxviruses vaccine, and COVID vaccines. Includes information on how to submit public comments or request permission to make a public comment during the meeting. Registration is not required, and the meeting is open to the public, available online via a live webcast. (Source: Federal Register upda...
Source: Federal Register updates via the Rural Assistance Center - October 21, 2021 Category: Rural Health Source Type: news
Guidelines for Infection Control in the Urological Field, including Urinary Tract Management (revised second edition)
The Committee for the Development of Guidelines for Infection Control in the Urological Field, including Urinary Tract Management of the Japanese Urological Association, together with its systematic review team and external reviewers, have prepared a set of practice guidelines, an abridged version of which is published herein. These guidelines cover the following topics: (i) foundations of infection control, standard precautions, route-specific precautions, and occupational infection control (including vaccines); (ii) the relationship between urologists and infection control; (iii) infection control in urological wards and...
Source: Current Awareness Service for Health (CASH) - October 15, 2021 Category: Consumer Health News Source Type: news
Africa: Africa CDC Welcomes Historic Go-Ahead for Malaria Vaccine
[African Union] The African continent is making headway in the fight against malaria among young children. Being at the forefront in establishing, strengthening, and supporting member states in disease control and surveillance for priority diseases including HIV and AIDs, tuberculosis, malaria, COIVD-19, hepatitis, and non-communicable diseases in the region, the African Union (AU) through the Africa Centres for Disease Control and Prevention (Africa CDC) has welcomed the World Health Organization's (WHO) historic go-ahea (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - October 11, 2021 Category: Infectious Diseases Source Type: news
